Recurrent Peptic Ulcers in Patients Following Successful Helicobacter pylori Eradication: A Multicenter Study of 4940 Patients
- 19 February 2004
- journal article
- research article
- Published by Wiley in Helicobacter
- Vol. 9 (1), 9-16
- https://doi.org/10.1111/j.1083-4389.2004.00194.x
Abstract
Objective. Although curative treatment of Helicobacter pylori infection markedly reduces the relapse of peptic ulcers, the details of the ulcers that do recur is not well characterized. The aim of this study is to describe the recurrence rate and specific features of peptic ulcers after cure of H. pylori infection. Methods. This was a multicenter study involving 4940 peptic ulcer patients who were H. pylori negative after successful eradication treatment and were followed for up to 48 months. The annual incidence of ulcer relapse in H. pylori‐cured patients, background of patients with relapsed ulcers, time to relapse, ulcer size, and site of relapsed ulcers were investigated. Results. Crude peptic ulcer recurrence rate was 3.02% (149/4940). The annual recurrence rates of gastric, duodenal and gastroduodenal ulcer were 2.3%, 1.6%, and 1.6%, respectively. Exclusion of patients who took NSAIDs led annual recurrence rates to 1.9%, 1.5% and 1.3%, respectively. The recurrence rate was significantly higher in gastric ulcer. Recurrence rates of patients who smoked, consumed alcohol, and used NSAIDs were significantly higher in those with gastric ulcer recurrence compared to duodenal ulcer recurrence (e.g. 125 of 149 [83.9%] relapsed ulcers recurred at the same or adjacent sites as the previous ulcers). Conclusions. Curative treatment of H. pylori infection is useful in preventing ulcer recurrence. Gastric ulcer is more likely to relapse than duodenal ulcer. Recurrent ulcer tended to recur at the site of the original ulcers.Keywords
This publication has 25 references indexed in Scilit:
- Association Between Nonsteroidal Anti-inflammatory Drugs and Upper Gastrointestinal Tract Bleeding/PerforationArchives of Internal Medicine, 2000
- Cure of Helicobacter pylori infection does not improve symptoms in non‐ulcer dyspepsia patients—a double‐blind placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2000
- Effect of Eradication of Helicobacter pylori on the Benign Gastric Ulcer Recurrence - A 24 month follow - up study-The Korean Journal of Internal Medicine, 1999
- Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus ReportEuropean Journal of Gastroenterology & Hepatology, 1997
- Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A reviewGastroenterology, 1996
- NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer DiseaseJAMA, 1994
- Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-upThe Lancet, 1994
- Aetiological factors of peptic ulcer: Perspectives of epidemiological observations this centuryJournal of Gastroenterology and Hepatology, 1994
- Prevalence of Helicobacter pylori Infection in Patients with Peptic Ulcer Diseases and Non-Ulcer DyspepsiaThe Korean Journal of Internal Medicine, 1993
- Loss of retinoblastoma gene and amplification of N-myc gene in retinoblastomaJournal of Korean Medical Science, 1993